rhMG53 decreases membrane damage <i>in vitro</i>. by Brian J. Paleo (8694246)

Currents of BK channel are decreased in CRL4^CRBN deficient glioma cells. by Tianyu Song (4797417)

Gal-9 treatment decreases levels of MMP-9, MMP-2 and TIMP-1 but not neutrophil chemoattractants in BALF. by Yuko Horio (4243405)

The M650K mutation decreases the firing rate of DRG neurons. by Andreas M. Kist (3106548)

The novel <i>carboxylesterase 1</i> variant c.662A>G may decrease the bioactivation of oseltamivir in humans by Jaeseong Oh (3947381)

“…</p><p>Methods</p><p>A single oral dose of oseltamivir at 75 mg was administered to 20 healthy subjects, 8 heterozygous c.662A>G carriers (c.662AG) and 12 non-carriers (c.662AA). …”

VH14PEST decreases the toxicity of α-Syn as measured by a proteostatic assay with mhttex1-72QGFP. by David C. Butler (261919)

Decreasing RhoB expression by siRNA transfection does not change Ad5wt attachment or internalization. by Dragomira Majhen (462312)

Decrease in extracellular Zn²⁺ in the hippocampus by zinc chelators. by Atsushi Takeda (18203)

“…<p>Hippocampal slices were prepared 2 h after i.p. injection of vehicle (A, n = 7) or CQ (30 mg/kg, B, n = 5) into NER, and 3 h after i.p. injection of vehicle (C, n = 7) or TPEN (1 mg/kg, D, n = 8) into NER. …”

LPS-induced decrease in Sp1 DNA binding activity is associated with an increased NF-κB binding activity. by Xiaobing Ye (49295)

“…(A) and (C): EMSA photographs show that LPS-induced decrease in Sp1 DNA binding activity is associated with an increased NF-κB binding activity.…”

Oligomycin decreases proteasome inhibition-induced cell death in the presence of Ade. by Shujue Li (466324)

PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis by Bushinsky D.A. (3246690)

“…On patiromer, P decreased from 7.0 ± 0.5 to 6.2 ± 0.5 mg/dl (p = 0.04). …”

Decreased microglial activation in TREM2-KO mice after stroke. by Matthias W. Sieber (106521)

Bcl6 deficiency decreases expression of lipogenic genes and proteins in liver. by Christopher R. LaPensee (571785)

Calpain protein expression level and enzyme activity are decreased in calpain mutants. by James B. Reinecke (346003)

SETD2 loss of function in BMSCs showed decreased bone mass. by Lijun Wang (176511)

Comparison of the decrease of CFU in CSF and blood between treatment groups within the first 6 h after treatment. by Luca G. Valente (12463057)

ADAR2 expression is decreased in the islets of JNK1 knockout mice. by Liu Yang (23752)

FX06 decreased capillary leak following LPS injection in rats. by Marion Gröger (264663)

The G357S mutation decreases both activation and termination thresholds for SOICR. by Yingjie Liu (317210)

Anti-AT prophylaxis decreases lesion size in <i>S. aureus</i> dermonecrosis. by Christine Tkaczyk (465528)